Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Koichiro Tobe is active.

Publication


Featured researches published by Koichiro Tobe.


Bioscience, Biotechnology, and Biochemistry | 2003

Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract.

Atsushi Sano; Jun Yamakoshi; Shoichi Tokutake; Koichiro Tobe; Yoshiro Kubota; Mamoru Kikuchi

To confirm the absorption of proanthocyanidin (PA) into the human body, four healthy adults were administered 2.0 g of PA-rich grape seed extract (GSE). Blood were drawn before intake and 2 h after intake. Through the enzymatic treatment of sulfatase and β-glucuronidase, blood samples were analyzed by HPLC coupled with mass-spectrometry (LC/MS). Procyanidin B1 [epicatechin-(4β→8)-catechin] was detected in human serum 2 h after intake. Its concentration was 10.6±2.5 nmol/l.


Carbohydrate Research | 1998

New enzymatic synthesis of 63-modified maltooligosaccharides and their inhibitory activities for human α-amylases

Riichiro Uchida; Ayako Nasu; Shoichi Tokutake; Kouichi Kasai; Koichiro Tobe; Nobuyuki Yamaji

Ten new 6(3)-modified maltopentaoses and tetraoses were synthesized by enzymatic reactions utilizing cyclodextrin glycosyltransferase (EC 2.4.1.19) and subsequent human salivary alpha-amylase (HSA) (EC 3.2.1.1). Among these compounds, alpha-D-glucopyranosyl-(1-->4)- alpha-D-glucopyranosyl-(1-->4)-(6-deoxy-alpha-D-glucopyranosyl)-(1-->4)- alpha-D-glucopyranosyl-(1-->4)-D-glucopyranose (11) and alpha-D-glucopyranosyl-(1-->4)-(6-deoxy-alpha-D-glucopyranosyl)-(1-->4)- alpha-D-glucopyranosyl-(1-->4)-D-glucopyranose (12) showed strong inhibitory activities for human pancreatic alpha-amylase (HPA) and HSA. The IC50 of 6(3)-deoxymaltopentaose 11 (8.0 x 10(-5) M for HPA, 1.0 x 10(-4) M for HSA) and 6(3)-deoxymaltotetraose 12 (2.0 x 10(-3) M for HPA, 2.0 x 10(-3) M for HSA) were lower than that of 6(3)-deoxymaltotriose [(6-deoxy-alpha-D-glucopyranosyl)-(1-->4)-alpha-D- glucopyranosyl-(1-->4)-D-glucopyranose 13; 2.0 x 10(-3) M for HPA, 4.2 x 10(-2) M for HSA].


Journal of Nutrition | 2000

Soy Isoflavone Aglycones Are Absorbed Faster and in Higher Amounts than Their Glucosides in Humans

Toru Izumi; Mariusz K. Piskula; Sachiko Osawa; Akio Obata; Koichiro Tobe; Makoto Saito; Shigehiro Kataoka; Yoshiro Kubota; Mamoru Kikuchi


Journal of Nutrition | 2000

Isoflavone Aglycone–Rich Extract without Soy Protein Attenuates Atherosclerosis Development in Cholesterol-Fed Rabbits

Jun Yamakoshi; Mariusz K. Piskula; Toru Izumi; Koichiro Tobe; Makoto Saito; Shigehiro Kataoka; Akio Obata; Mamoru Kikuchi


Archive | 2000

Anti-arteriosclerotic food

Jun Yamakoshi; Makoto Saito; Akio Obata; Toru Izumi; Koichiro Tobe


Archive | 2001

Process for producing isoflavone aglycone-containing composition

Akio Obata; Tatuo Manaka; Koichiro Tobe; Toru Izumi; Makoto Saito; Mamoru Kikuchi


Chemical & Pharmaceutical Bulletin | 1999

Synthesis of new N-containing maltooligosaccharides, α-amylase inhibitors, and their biological activities

Riichiro Uchida; Ayako Nasu; Shoichi Tokutake; Kouichi Kasai; Koichiro Tobe; Nobuyuki Yamaji


Archive | 2000

Malto-oligosaccharide derivatives and uses thereof

Riichiro Uchida; Ayako Nasu; Yukihiko Iwai; Takao Someya; Koichiro Tobe


Archive | 1998

Cyclic oligosaccharide, and an agent containing the same for preventing or treating retroviral diseases

Koichiro Tobe; Makoto Saito; Shoichi Tokutake; Satoshi Kitao; Tetsuya Oguma; Kahee Fujita


Journal of the Society of Brewing, Japan | 1996

Simple Measurement of ^|^alpha;-Amylase Activity in Rice Koji

Yoshio Shirokane; Shoichi Tokutake; Koichiro Tobe; Masaru Suzuki

Collaboration


Dive into the Koichiro Tobe's collaboration.

Researchain Logo
Decentralizing Knowledge